PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. thomas.vanassche@uzleuven.be.\', \'Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium. thomas.vanassche@uzleuven.be.\', \'Center for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.\', \'Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium.\', \'Center for Cancer Biology, VIB, Leuven, Belgium.\', \'Department of General Internal Medicine, Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.\', \'Clinical Department and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.\', \'Pediatric Rheumatology, University Hospitals Leuven, Leuven, Belgium.\', \'Laboratory of Adaptive Immunology & Immunobiology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.\', \'Department of Anesthesiology, University Hospitals Leuven, Leuven, Belgium.\', \'REGA Institute, KU Leuven, Leuven, Belgium.\', \'Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BioStat), KU Leuven, Leuven, and Hasselt University (UHasselt), Hasselt, Belgium.\', \'Department of Respiratory Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium.\', \'Department of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.\', \'Department of Anaesthesiology, Intensive Care, Emergency Medicine and Pain Therapy, Ziekenhuis Oost-Limburg, Genk, Belgium.\', \'Department of Anesthestiology, GZA hospital group, Antwerp, Belgium.\', \'Emergency Medicine and Intensive Care, GZA hospital group, Antwerp, Belgium.\', \'Respiratory Medicine, GZA hospital group, Antwerp, Belgium.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-020-04878-y
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33298149
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33298149>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33298149>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all